NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| FTIXX | Goldman Sachs Financial Square Treasury Instruments Fund Institutional Shares | 12.95% | ||
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.99% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.94% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.88% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 1.84% |
| MBX | MBX Biosciences, Inc. Common Stock | Healthcare | Biotechnology | 1.78% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.69% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 1.68% |
| EWTX | Edgewise Therapeutics Inc | Healthcare | Biotechnology | 1.63% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.55% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.54% |
| MNMD | Mind Medicine Inc | Healthcare | Biotechnology | 1.52% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.50% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 1.50% |
| AMRX | Amneal Pharmaceuticals, Inc. Class A Common Stock | Healthcare | Drug Manufacturers - Specialty & Generic | 1.48% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.48% |
| PRGO | Perrigo Company PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.47% |
| PBH | Prestige Brand Holdings Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.45% |
| XERS | Xeris Pharmaceuticals Inc | Healthcare | Biotechnology | 1.45% |